Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone in Allergic Asthma
NCT00604578Phase 2Withdrawn
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Jan 2008
- Primary completion
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in allergic asthma comparing Pioglitazone with Placebo (2 arms). Primary endpoint: Change in post-bronchodilator FEV1 at 10 weeks. Planned start Jan 2008; status: withdrawn.
02
Drugs
pioglitazone
03
Conditions
allergic asthma
Beyond the preview
Go deeper on NCT00604578.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00604578.